How clinically relevant is statin-induced diabetes?

Lancet Diabetes Endocrinol. 2024 May;12(5):286-287. doi: 10.1016/S2213-8587(24)00059-7. Epub 2024 Mar 27.

Authors

Hertzel C Gerstein¹, Marie Pigeyre²

Affiliations

¹ Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON L8S 4K1, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: gerstein@mcmaster.ca.
² Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.

PMID: 38554714
DOI: 10.1016/S2213-8587(24)00059-7

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus / chemically induced
Diabetes Mellitus / drug therapy
Diabetes Mellitus, Type 2 / drug therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors